Rivaroxaban - NDC Database
33342-488 May 14, 2025
Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
46708-346 May 14, 2025
Rivaroxaban 10 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
Rivaroxaban 10 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
46708-347 May 14, 2025
Rivaroxaban 15 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
Rivaroxaban 15 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
46708-348 May 14, 2025
Rivaroxaban 20 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
Rivaroxaban 20 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
46708-683 May 14, 2025
Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
Rivaroxaban 2.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
51672-4228 Oct 15, 2025
Rivaroxaban 2.5 mg Oral Tablet, Coated by Sun Pharmaceutical Industries, Inc.
Rivaroxaban 2.5 mg Oral Tablet, Coated by Sun Pharmaceutical Industries, Inc.
55488-0540 Feb 01, 2026
Rivaroxaban 10 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
Rivaroxaban 10 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
55488-0541 Feb 01, 2026
Rivaroxaban 15 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
Rivaroxaban 15 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
55488-0542 Feb 01, 2026
Rivaroxaban 20 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
Rivaroxaban 20 mg Oral Tablet, Film Coated by Changzhou Pharmaceutical Factory
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.